ReviewMedical oncology (Northwood, London, England)2026

Breaking adaptive oncogenic resistance in glioblastoma via targeting the EGFR-STAT3 axis.

Nisar Ahmad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.